Unraveling Amentoflavone's Therapeutic Potential in Alzheimer's Disease: A Preclinical Assessment


Цитировать

Полный текст

Аннотация

Alzheimer’s disease is one of the neurodegenerative diseases which causes cognition deficit. There are currently few medications available to treat Alzheimer's disease, even though researchers have devoted a great deal of time studying the condition and offering many benefits. Thus, only a few drugs are available for the treatment of Alzheimer’s disease. Amentoflavone is a dietary component found in many plants and herbs that has several health advantages. Amentoflavone has demonstrated strong protective benefits against a range of brain illnesses in preclinical trials, most frequently in Alzheimer's disease. Amentoflavone, a biflavonoid, can be identified in a variety of herbs upon isolation. Considering the beneficial properties of this compound, this review emphasizes the pharmacological effects and botanical sources of amentoflavone, as well as the compound's benefits and possible applications in the treatment of Alzheimer's disorders.

Об авторах

Sushma Singh

Institute of Pharmaceutical Research, GLA University

Email: info@benthamscience.net

Neetu Agrawal

Institute of Pharmaceutical Research, GLA University

Email: info@benthamscience.net

Ahsas Goyal

Institute of Pharmaceutical Research, GLA University

Автор, ответственный за переписку.
Email: info@benthamscience.net

Список литературы

  1. Ishola, I.O.; Chatterjee, M.; Tota, S.; Tadigopulla, N.; Adeyemi, O.O.; Palit, G.; Shukla, R. Pharmacology, biochemistry and behavior antidepressant and anxiolytic effects of amento Fl avone isolated from Cnestis Ferruginea in mice. Pharmacol. Biochem. Behav., 2012, 103, 322-331. doi: 10.1016/j.pbb.2012.08.017 PMID: 22944105
  2. de Teles, A.R.B.; Diniz, T.C.; Pinto, C.T.C.; de Júnior, O.R.G.; Gama e Silva, M.; de Lavor, É.M.; Fernandes, A.W.C.; de Oliveira, A.P.; de Ribeiro, A.F.P.R.; da Silva, A.A.M.; Cavalcante, T.C.F.; Júnior, Q.L.J.; da Almeida, S.J.R.G. Flavonoids as therapeutic agents in Alzheimer’s and parkinson’s diseases: A systematic review of preclinical evidences. Oxid. Med. Cell. Longev., 2018, 2018, 1-21. doi: 10.1155/2018/7043213 PMID: 29861833
  3. Minter, M.R.; Taylor, J.M.; Crack, P.J. The contribution of neuroinflammation to amyloid toxicity in Alzheimer’s disease. J. Neurochem., 2016, 136(3), 457-474. doi: 10.1111/jnc.13411 PMID: 26509334
  4. AlMatar, M.; Makky, E.A.; Ramli, A.N.M. Natural polysaccharides alleviate neurological disorders: New updates. Mini Rev. Med. Chem., 2022, 22(22), 2813-2819. doi: 10.2174/1389557522666220321145840 PMID: 35319363
  5. Gregory, J.; Vengalasetti, Y.V.; Bredesen, D.E.; Rao, R.V. Neuroprotective herbs for the management of Alzheimer’s disease. Biomolecules, 2021, 11(4), 543. doi: 10.3390/biom11040543 PMID: 33917843
  6. Iriti, M.; Vitalini, S.; Fico, G.; Faoro, F. Neuroprotective herbs and foods from different traditional medicines and diets. Molecules, 2010, 15(5), 3517-3555. doi: 10.3390/molecules15053517 PMID: 20657497
  7. Minocha, T.; Birla, H.; Obaid, A.A.; Rai, V.; Sushma, P.; Shivamallu, C.; Moustafa, M.; Al-Shehri, M.; Al-Emam, A.; Tikhonova, M.A.; Yadav, S.K.; Poeggeler, B.; Singh, D.; Singh, S.K. Flavonoids as promising neuroprotectants and their therapeutic potential against Alzheimer’s disease. Oxid. Med. Cell. Longev., 2022, 2022, 6038996. doi: 10.1155/2022/6038996
  8. Khan, J.; Deb, P.K.; Priya, S.; Medina, K.D.; Devi, R.; Walode, S.G.; Rudrapal, M. Dietary flavonoids: Cardioprotective potential with antioxidant effects and their pharmacokinetic, toxicological and therapeutic concerns. Molecules, 2021, 26(13), 4021. doi: 10.3390/molecules26134021 PMID: 34209338
  9. Hussain, M.; Jabeen, N.; Amanullah, A.; Ashraf Baig, A.; Aziz, B.; Shabbir, S.; Raza, F.; Uddin, N. Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: Conformation and intermolecular interactions. AIMS Microbiol., 2020, 6(3), 350-360. doi: 10.3934/microbiol.2020021 PMID: 33029570
  10. He, X.; Yang, F.; Huang, X. Proceedings of chemistry, pharmacology, pharmacokinetics and synthesis of biflavonoids. Molecules, 2021, 26(19), 6088. doi: 10.3390/molecules26196088
  11. Sirimangkalakitti, N.; Juliawaty, L.D.; Hakim, E.H.; Waliana, I.; Saito, N.; Koyama, K.; Kinoshita, K. Naturally occurring biflavonoids with amyloid β aggregation inhibitory activity for development of anti-Alzheimer agents. Bioorg. Med. Chem. Lett., 2019, 29(15), 1994-1997. doi: 10.1016/j.bmcl.2019.05.020 PMID: 31138471
  12. Thapa, A.; Woo, E.R.; Chi, E.Y.; Sharoar, M.G.; Jin, H.G.; Shin, S.Y.; Park, I.S. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures. Biochemistry, 2011, 50(13), 2445-2455. doi: 10.1021/bi101731d PMID: 21322641
  13. Han, B.H.; Cofell, B.; Everhart, E.; Humpal, C.; Kang, S.S.; Lee, S.K.; Kim-Han, J.S. Amentoflavone promotes cellular uptake and degradation of amyloid-beta in neuronal cells. Int. J. Mol. Sci., 2022, 23(11), 5885. doi: 10.3390/ijms23115885 PMID: 35682567
  14. Portilla-Martínez, A.; Ortiz-Flores, M.; Hidalgo, I.; Gonzalez-Ruiz, C.; Meaney, E.; Ceballos, G.; Nájera, N. In silico evaluation of flavonoids as potential inhibitors of SARS-CoV-2 main nonstructural proteins (Nsps)—Amentoflavone as a multitarget candidate. J. Mol. Model., 2022, 28(12), 404. doi: 10.1007/s00894-022-05391-6 PMID: 36445575
  15. Jeong, E.J.; Hwang, L.; Lee, M.; Lee, K.Y.; Ahn, M.J.; Sung, S.H. Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells. Food Chem. Toxicol., 2014, 64, 397-402. doi: 10.1016/j.fct.2013.12.003 PMID: 24315869
  16. Yu, S.; Yan, H.; Zhang, L.; Shan, M.; Chen, P.; Ding, A.; Li, S. A review on the phytochemistry, pharmacology, and pharmacokinetics of amentoflavone, a naturally-occurring biflavonoid. Molecules, 2017, 22(2), 299. doi: 10.3390/molecules22020299 PMID: 28212342
  17. Rong, S.; Yang, C.; Wang, F.; Wu, Y.; Sun, K.; Sun, T.; Wu, Z. Amentoflavone exerts anti-neuroinflammatory effects by inhibiting TLR4/MyD88/NF-κB and activating Nrf2/HO-1 pathway in lipopolysaccharide-induced BV2 microglia. Mediators Inflamm., 2022, 2022, 1-12. doi: 10.1155/2022/5184721 PMID: 36523959
  18. Singh, A.V. Potential of amentoflavone with antiviral properties in COVID-19 treatment. Asian Biomed., 2021, 15(4), 153-159. doi: 10.2478/abm-2021-0020 PMID: 37551327
  19. Yen, T.H.; Hsieh, C.L.; Te Liu, T.; Huang, C.S.; Chen, Y.C.; Chuang, Y.C.; Lin, S.S.; Hsu, F.T. Amentoflavone induces apoptosis and inhibits nf-ĸb-modulated anti-apoptotic signaling in glioblastoma cells. In Vivo, 2018, 32, 279-285.
  20. Feng, X.; Chen, Y.; Li, L.; Zhang, Y.; Zhang, L.; Zhang, Z. Preparation, evaluation and metabolites study in rats of novel amentoflavone-loaded TPGS/soluplus mixed nanomicelles. Drug Deliv., 2020, 27(1), 137-150. doi: 10.1080/10717544.2019.1709920 PMID: 31913733
  21. Roos, K.; Wu, C.; Damm, W.; Reboul, M.; Stevenson, J.M.; Lu, C.; Dahlgren, M.K.; Mondal, S.; Chen, W.; Wang, L.; Abel, R.; Friesner, R.A.; Harder, E.D. OPLS3e: Extending force field coverage for drug-like small molecules. J. Chem. Theory Comput., 2019, 15(3), 1863-1874. doi: 10.1021/acs.jctc.8b01026 PMID: 30768902
  22. Chen, J.H.; Chen, W.L.; Liu, Y.C. Amentoflavone induces anti-angiogenic and anti-metastatic effects through suppression of NF-κB activation in MCF-7 cells. Anticancer Res., 2015, 35(12), 6685-6693. PMID: 26637885
  23. Kim, S.Y.; Choi, S.H.; Rollema, H.; Schwam, E.M.; McRae, T.; Dubrava, S.; Jacobsen, J.; Phase, I.I. Phase II crossover trial of varenicline in mild-to-moderate Alzheimer’s disease. Dement. Geriatr. Cogn. Disord., 2014, 37(3-4), 232-245. doi: 10.1159/000355373 PMID: 24247022
  24. Lee, K.C.; Tsai, J.J.; Tseng, C.W.; Kuo, Y.C.; Chuang, Y.C.; Lin, S.S.; Hsu, F.T. Amentoflavone inhibits ERK-modulated tumor progression in hepatocellular carcinoma in vitro. In Vivo, 2018, 32, 549-554.
  25. Cholbi, M.R.; Paya, M.; Alcaraz, M.J. Inhibitory effects of phenolic compounds on CCl4-induced microsomal lipid peroxidation. Experientia, 1991, 47(2), 195-199. doi: 10.1007/BF01945426 PMID: 2001725
  26. Wang, F.; Zhang, Z.; Sun, T.; Niu, J.; He, Z.; Liu, Y. Amentoflavone protects hippocampal neurons: anti-inflammatory, antioxidative, and antiapoptotic effects. Neural Regen. Res., 2015, 10(7), 1125-1133. doi: 10.4103/1673-5374.160109 PMID: 26330838
  27. Jung, H.J.; Park, K.; Lee, I.S.; Kim, H.S.; Yeo, S.H.; Woo, E.R.; Lee, D.G. S-phase accumulation of Candida albicans by anticandidal effect of amentoflavone isolated from Selaginella tamariscina. Biol. Pharm. Bull., 2007, 30(10), 1969-1971. doi: 10.1248/bpb.30.1969 PMID: 17917274
  28. Coulerie, P.; Eydoux, C.; Hnawia, E.; Stuhl, L.; Maciuk, A.; Lebouvier, N.; Canard, B.; Figadère, B.; Guillemot, J.C.; Nour, M. Biflavonoids of dacrydium balansae with potent inhibitory activity on dengue 2 NS5 polymerase. Planta Med., 2012, 78(7), 672-677. doi: 10.1055/s-0031-1298355 PMID: 22411725
  29. Lin, Y.M.; Anderson, H.; Flavin, M.T.; Pai, Y.H.S.; Greenwood, M.E.; Pengsuparp, T.; Pezzuto, J.M.; Schinazi, R.F.; Hughes, S.H.; Chen, F.C. In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora. J. Nat. Prod., 1997, 60(9), 884-888. doi: 10.1021/np9700275 PMID: 9322359
  30. Kim, H.K.; Son, K.H.; Chang, H.W.; Kang, S.S.; Kim, H.P. Amentoflavone, a plant biflavone: A new potential anti-inflammatory agent. Arch. Pharm. Res., 1998, 21(4), 406-410. doi: 10.1007/BF02974634 PMID: 9875467
  31. Guruvayoorappan, C.; Kuttan, G. Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F-10 melanoma cells in C57BL/6 mice. Integr. Cancer Ther., 2007, 6(2), 185-197. doi: 10.1177/1534735407302345 PMID: 17548797
  32. Choi, E.Y.; Kang, S.S.; Lee, S.K.; Han, B.H. Polyphenolic biflavonoids inhibit amyloid-beta fibrillation and disaggregate preformed amyloid-beta fibrils. Biomol. Ther., 2020, 28(2), 145-151. doi: 10.4062/biomolther.2019.113 PMID: 31697876
  33. Hampel, H.; Toschi, N.; Babiloni, C.; Baldacci, F.; Black, K.L.; Bokde, A.L.W.; Bun, R.S.; Cacciola, F.; Cavedo, E.; Chiesa, P.A.; Colliot, O.; Coman, C.M.; Dubois, B.; Duggento, A.; Durrleman, S.; Ferretti, M.T.; George, N.; Genthon, R.; Habert, M.O.; Herholz, K.; Koronyo, Y.; Koronyo-Hamaoui, M.; Lamari, F.; Langevin, T.; Lehéricy, S.; Lorenceau, J.; Neri, C.; Nisticò, R.; Nyasse-Messene, F.; Ritchie, C.; Rossi, S.; Santarnecchi, E.; Sporns, O.; Verdooner, S.R.; Vergallo, A.; Villain, N.; Younesi, E.; Garaci, F.; Lista, S. Revolution of alzheimer precision neurology. Passageway of systems biology and neurophysiology. J. Alzheimers Dis., 2018, 64(s1), S47-S105. doi: 10.3233/JAD-179932 PMID: 29562524
  34. Su, C.; Yang, C.; Gong, M.; Ke, Y.; Yuan, P.; Wang, X.; Li, M.; Zheng, X.; Feng, W. Antidiabetic activity and potential mechanism of amentoflavone in diabetic mice. Molecules, 2019, 24(11), 2184. doi: 10.3390/molecules24112184 PMID: 31212585
  35. Xu, Z.Q.; Zhang, W.J.; Su, D.F.; Zhang, G.Q.; Miao, C.Y. Cellular responses and functions of α7 nicotinic acetylcholine receptor activation in the brain: A narrative review. Ann. Transl. Med., 2021, 9(6), 509. doi: 10.21037/atm-21-273 PMID: 33850906
  36. Rizk, Y.S.; Pereira, S.S.; Gervazoni, L.; Hardoim, D.J.; Cardoso, F.O.; de Souza, C.S.F.; Machado, P.M.; Carollo, C.A.; de Arruda, C.C.P.; Amaral, A.E.E.; do-Valle, Z.T.; Calabrese, K.S. Amentoflavone as an ally in the treatment of cutaneous leishmaniasis: Analysis of its antioxidant/prooxidant mechanisms. Front. Cell. Infect. Microbiol., 2021, 11, 615814. doi: 10.3389/fcimb.2021.615814
  37. Ishola, I.O.; Tota, S.; Adeyemi, O.O.; Agbaje, E.O.; Narender, T.; Shukla, R. Protective effect of Cnestis ferruginea and its active constituent on scopolamine-induced memory impairment in mice: A behavioral and biochemical study. Pharm. Biol., 2013, 51(7), 825-835. doi: 10.3109/13880209.2013.767360 PMID: 23627469
  38. Bais, S.; Abrol, N.; Prashar, Y. kumari, R. Modulatory effect of standardised amentoflavone isolated from Juniperus communis L. agianst Freund’s adjuvant induced arthritis in rats (histopathological and X Ray anaysis). Biomed. Pharmacother., 2017, 86, 381-392. doi: 10.1016/j.biopha.2016.12.027 PMID: 28012393
  39. Frota, L.S.; Alves, D.R.; Marinho, M.M.; Paes, L.; Wagner, F.; Almeida, D.Q.; Marinho, E.S.; De Morais, S.M.; Soares, L.; Alves, D.R.; Marinho, M.M. Antioxidant and anticholinesterase activities of amentoflavone isolated from antioxidant and anticholinesterase activities of amentoflavone isolated from ouratea fieldingiana (Gardner) Engl. through in vitro and chemical- quantum studies. J. Biomol. Struct. Dyn., 2023, 41(4), 1208-1216. PMID: 34907850
  40. Yue, S.; Kang, W. Lowering blood lipid and hepatoprotective activity of amentoflavone from selaginella tamariscina in Vivo. J. Med. Plants Res., 2011, 5, 3007-3014.
  41. Ma, S.C.; But, P.P.H.; Ooi, V.E.C.; He, Y.H.; Lee, S.H.S.; Lee, S.F.; Lin, R.C. Antiviral amentoflavone from Selaginella sinensis. Biol. Pharm. Bull., 2001, 24(3), 311-312. doi: 10.1248/bpb.24.311 PMID: 11256492
  42. Bucar, F.; Jachak, S.; Noreem, Y.; Kartnig, T.; Perera, P.; Bohlin, L.; Zsilavecz, S.M. Amentoflavone from Biophytum sensitivum and its effect on COX-1/COX-2 catalysed prostaglandin biosynthesis. Planta Med., 1998, 64(4), 373-374. doi: 10.1055/s-2006-957455 PMID: 17253252
  43. Chakravarthy, B.; Rao, Y.; Gambhir, S.; Gode, K. Isolation of amentoflavone from Selaginella rupestris and its pharmacological activity on central nervous system, smooth muscles and isolated frog heart preparations. Planta Med., 1981, 43(9), 64-70. doi: 10.1055/s-2007-971475 PMID: 7345444
  44. Oh, J.; Rho, H.S.; Yang, Y.; Yoon, J.Y.; Lee, J.; Hong, Y.D.; Kim, H.C.; Choi, S.S.; Kim, T.W.; Shin, S.S.; Cho, J.Y. Extracellular signal-regulated kinase is a direct target of the anti-inflammatory compound amentoflavone derived from Torreya nucifera. Mediators Inflamm., 2013, 2013, 1-11. doi: 10.1155/2013/761506 PMID: 23970815
  45. Bajpai, V.K.; Park, I.; Lee, J.; Shukla, S.; Nile, S.H.; Chun, H.S.; Khan, I.; Oh, S.Y.; Lee, H.; Huh, Y.S.; Na, M.; Han, Y.K. Antioxidant and antimicrobial efficacy of a biflavonoid, amentoflavone from Nandina domestica in vitro and in minced chicken meat and apple juice food models. Food Chem., 2019, 271, 239-247. doi: 10.1016/j.foodchem.2018.07.159 PMID: 30236673
  46. Hammer, K.D.P.; Hillwig, M.L.; Solco, A.K.S.; Dixon, P.M.; Delate, K.; Murphy, P.A.; Wurtele, E.S.; Birt, D.F. Inhibition of prostaglandin E(2) production by anti-inflammatory hypericum perforatum extracts and constituents in RAW264.7 Mouse Macrophage Cells. J. Agric. Food Chem., 2007, 55(18), 7323-7331. doi: 10.1021/jf0710074 PMID: 17696442
  47. Krauze-Baranowska, M.; Wiwart, M. Antifungal activity of biflavones from Taxus baccata and Ginkgo biloba. Z. Naturforsch. C J. Biosci., 2003, 58(1-2), 65-69. doi: 10.1515/znc-2003-1-212 PMID: 12622229
  48. Sannomiya, M.; Fonseca, V.B.; da Silva, M.A.; Rocha, L.R.M.; dos Santos, L.C.; Hiruma-Lima, C.A.; Souza Brito, A.R.M.; Vilegas, W. Flavonoids and antiulcerogenic activity from Byrsonima crassa leaves extracts. J. Ethnopharmacol., 2005, 97(1), 1-6. doi: 10.1016/j.jep.2004.09.053 PMID: 15652267
  49. Kaikabo, A.A.; Eloff, J.N. Antibacterial activity of two biflavonoids from Garcinia livingstonei leaves against Mycobacterium smegmatis. J. Ethnopharmacol., 2011, 138(1), 253-255. doi: 10.1016/j.jep.2011.08.023 PMID: 21920421
  50. Bagla, V.P.; McGaw, L.J.; Elgorashi, E.E.; Eloff, J.N. Antimicrobial activity, toxicity and selectivity index of two biflavonoids and a flavone isolated from Podocarpus henkelii (Podocarpaceae) leaves. BMC Complement. Altern. Med., 2014, 14(1), 383. doi: 10.1186/1472-6882-14-383 PMID: 25293523
  51. Kunert, O.; Swamy, R.C.; Kaiser, M.; Presser, A.; Buzzi, S.; Appa Rao, A.V.N.; Schühly, W. Antiplasmodial and leishmanicidal activity of biflavonoids from Indian Selaginella bryopteris. Phytochem. Lett., 2008, 1(4), 171-174. doi: 10.1016/j.phytol.2008.09.003
  52. Zhao, N.; Sun, C.; Zheng, M.; Liu, S.; Shi, R. Amentoflavone suppresses amyloid β1–42 neurotoxicity in Alzheimer’s disease through the inhibition of pyroptosis. Life Sci., 2019, 239, 117043. doi: 10.1016/j.lfs.2019.117043 PMID: 31722188
  53. Sun, L.; Sharma, A.K.; Han, B.H.; Mirica, L.M. Amentoflavone: A bifunctional metal chelator that controls the formation of neurotoxic soluble Aβ 42 oligomers. ACS Chem. Neurosci., 2020, 11(17), 2741-2752. doi: 10.1021/acschemneuro.0c00376 PMID: 32786307
  54. Shin, D.H.; Bae, Y.C.; Kim-Han, J.S.; Lee, J.H.; Choi, I.Y.; Son, K.H.; Kang, S.S.; Kim, W.K.; Han, B.H. Polyphenol amentoflavone affords neuroprotection against neonatal hypoxic‐ischemic brain damage via multiple mechanisms. J. Neurochem., 2006, 96(2), 561-572. doi: 10.1111/j.1471-4159.2005.03582.x PMID: 16336627
  55. Cao, B.; Zeng, M.; Zhang, Q.; Zhang, B.; Cao, Y.; Wu, Y.; Feng, W.; Zheng, X. Amentoflavone ameliorates memory deficits and abnormal autophagy in Aβ25−35-induced mice by mTOR signaling. Neurochem. Res., 2021, 46(4), 921-934. doi: 10.1007/s11064-020-03223-8 PMID: 33492604
  56. Cao, Q.; Qin, L.; Huang, F.; Wang, X.; Yang, L.; Shi, H.; Wu, H.; Zhang, B.; Chen, Z.; Wu, X. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson’s disease model mice through PI3K/Akt and ERK signaling pathways. Toxicol. Appl. Pharmacol., 2017, 319, 80-90. doi: 10.1016/j.taap.2017.01.019 PMID: 28185818
  57. Sasaki, H. Miki, K.; Kinoshita, K.; Koyama, K.; Juliawaty, L.D.; Achmad, S.A.; Hakim, E.H.; Kaneda, M.; Takahashi, K. β-Secretase (BACE-1) inhibitory effect of biflavonoids. Bioorg. Med. Chem. Lett., 2010, 20(15), 4558-4560. doi: 10.1016/j.bmcl.2010.06.021 PMID: 20598535
  58. Chen, Y.; Li, N.; Wang, H.; Wang, N.; Peng, H.; Wang, J.; Li, Y.; Liu, M.; Li, H.; Zhang, Y.; Wang, Z. Amentoflavone suppresses cell proliferation and induces cell death through triggering autophagy-dependent ferroptosis in human glioma. Life Sci., 2020, 247, 117425. doi: 10.1016/j.lfs.2020.117425 PMID: 32057904
  59. Sabogal-Guáqueta, A.M.; Carrillo-Hormaza, L.; Osorio, E.; Gómez, C.G.P. Effects of biflavonoids from Garcinia madruno on a triple transgenic mouse model of Alzheimer’s disease. Pharmacol. Res., 2018, 129, 128-138. doi: 10.1016/j.phrs.2017.12.002 PMID: 29229355
  60. Ashwal, S.; Pearce, W.J. Animal models of neonatal stroke. Curr. Opin. Pediatr., 2001, 13(6), 506-516. doi: 10.1097/00008480-200112000-00003 PMID: 11753098
  61. Halder, S.; Anand, U.; Nandy, S.; Oleksak, P.; Qusti, S.; Alshammari, E.M.; Batiha, E.S.G.; Koshy, E.P.; Dey, A. Herbal drugs and natural bioactive products as potential therapeutics: A review on pro-cognitives and brain boosters perspectives. Saudi Pharm. J., 2021, 29(8), 879-907. doi: 10.1016/j.jsps.2021.07.003 PMID: 34408548
  62. Vargas, B.D.; Shi, J.; Yaeger, D.M.; Ager, R.; LaFerla, F.M. Diabetes and Alzheimer’s disease crosstalk. Neurosci. Biobehav. Rev., 2016, 64, 272-287. doi: 10.1016/j.neubiorev.2016.03.005 PMID: 26969101
  63. Xiong, X.; Tang, N.; Lai, X.; Zhang, J.; Wen, W.; Li, X.; Li, A.; Wu, Y.; Liu, Z. Insights into amentoflavone: A natural multifunctional biflavonoid. Front. Pharmacol., 2021, 12, 768708. doi: 10.3389/fphar.2021.768708 PMID: 35002708
  64. Chang, B.S.; Lowenstein, D.H. Epilepsy. N. Engl. J. Med., 2003, 349(13), 1257-1266. doi: 10.1056/NEJMra022308 PMID: 14507951
  65. Rong, S.; Wan, D.; Fan, Y.; Liu, S.; Sun, K.; Huo, J.; Zhang, P.; Li, X.; Xie, X.; Wang, F.; Sun, T. Amentoflavone affects epileptogenesis and exerts neuroprotective effects by inhibiting NLRP3 inflammasome. Front. Pharmacol., 2019, 10, 856. doi: 10.3389/fphar.2019.00856 PMID: 31417409
  66. Verma, A.; Chaudhary, S.; Solanki, K.; Goyal, A.; Yadav, H.N. Exendin‐4: A potential therapeutic strategy for Alzheimer’s disease and Parkinson’s disease. Chem. Biol. Drug Des., 2024, 103(1), e14426. doi: 10.1111/cbdd.14426 PMID: 38230775

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2024